GE, Osprey announce distribution deal

2020 01 29 18 12 5932 Ge Rsna 2019 400

GE Healthcare and Osprey Medical have signed a four-year agreement under which GE will distribute Osprey's DyeVert contrast minimization device in Europe, Russia, the Middle East, Africa, Central Asia, and Turkey.

The partnership will help clinicians minimize acute kidney injury complications after interventional coronary angiograms in patients with chronic kidney disease, according to GE. DyeVert reduces the amount of contrast in the kidney by about 40%, GE said.

Page 1 of 550
Next Page